Skip to content

Glycocalyx measurements in premature atherosclerosis

Glycocalyx measurements in premature atherosclerosis - Glycocalyx measurements in premature atherosclerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON30991
Enrollment
40
Registered
2007-10-08
Start date
2007-10-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis vascular abnormalities

Interventions

Not applicable.

Sponsors

Academisch Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Cases: - a cardiac, cerebral or peripheral vascular disease before the age of 40 - a positive family history for cardiovascular disease, defined as a first degree family member with a cardiovascular event before the age of 55 for men and 60 for women. Furthermore, they should be between the age of 35 and 55 years old. Controls: -Controls will be defined as healthy in case they have no cardiovascular history, such as no cardiac, cerebrovascular or peripheral artery disease and no complaints of angina, claudication or TIA and no family history for cardiovascular disease. Furthermore, they should be between the age of 35 and 55 years old.

Exclusion criteria

Exclusion criteria: Cases: - a positive history for hypertension or diabetes mellitus - pregnancy or lactating women - subjects below the age of 18 - unable to give informed consent Controls: Diseases mentioned at the inclusioncriteria.

Design outcomes

Primary

MeasureTime frame
Changes in the volume of the intravascular glycocalyx between the different subjectgroups.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)